MariaWGreenwaldMD

Rheumatology • Palm Desert, CA

Associate Clinical Professor of Surgery, Loma Linda University

Join to view full profile

Dr. Greenwald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Greenwald's full profile

Already have an account?

Office
72855 Fred Waring Dr
Ste A6
Palm Desert, CA 92260
Phone+1 760-341-6800

Fax+1 760-341-9872

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1986 - 1987
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1984 - 1986
Yale-New Haven Medical CenterResidency, Internal Medicine, 1980 - 1983
Yale School of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1983 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Palm Springs Life Magazine Castle Connolly, 2006-2014
Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:San Diego Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22
Terminated
Phase 2
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Start of enrollment: 2016 Aug 02
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment.
Atul Deodhar, Alan J Kivitz, Marina Magrey, Jessica A Walsh, Philip J Mease
Rheumatology. 2024-08-12
2 citations
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients.
Christina Charles-Schoeman, Roy Fleischmann, Eduardo Mysler, Maria Greenwald, Steven R Ytterberg
Arthritis & Rheumatology. 2024-08-01
Hearing Loss As A Surrogate Marker For Early Atherosclerosis in A High-Risk Population: A Prospective Study.
Maria Greenwald, Steven Gunberg, Joann Ball, Denise Garcia
The American Journal of Cardiology. 2024-01-15

Authored Content

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid ArthritisOctober 2022

Press Mentions

Rituximab Combined with a TNF Inhibitor and Methotrexate Shows No Safety Signal in Rheumatoid Arthritis Treatment, Study FindsMarch 8th, 2011

Professional Memberships

American College of Rheumatology - ACR
Fellow